News Sentiment

BGLC sentiment intelligence

BioNexus Gene Lab Corp Common stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Basic Materials Market context
Industry Specialty Chemicals Read-through group
Latest close 1.81 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 59

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-10.8% over one week, -15.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Brenntag stock holds steady as the chemicals distributor focuses on earnings and portfolio strategy

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -10.8% Price reacting lower
Trend fit Trend inactive -15.4% over four weeks
Fair value -65.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 38
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 59
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Ad-hoc-news.de 9
TradingView 8
TradingKey 6
Stock Titan 4
dars.gov.et 4
Market source 3
DonanımHaber 3
Moomoo 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 14
Guidance 5
Macro sensitivity 3
Deals and strategy 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 59
TradingView Direct company coverage

Enterprise value to revenue forward of BioNexus Gene Lab Corp – NASDAQ:BGLC

The article focuses on the enterprise value to revenue forward metric for BioNexus Gene Lab Corp (NASDAQ: BGLC). It presents the stock's financial overview on TradingView, indicating that the market was closed with no trades at the time of publication. The content is primarily a

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 08:39
Source
TradingView
TradingView Direct company coverage

Price to sales forward of BioNexus Gene Lab Corp – NASDAQ:BGLC

This article provides financial information for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its forward price-to-sales ratio. It indicates that the market was closed at the time of publication and no trades had occurred. The data is presented within the contex

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 03:09
Source
TradingView
Moomoo Direct company coverage

BioNexus Gene Lab Company Profile & Introduction

The article provides a company profile and introduction for BioNexus Gene Lab. It offers basic information about the company.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 22:40
Source
Moomoo
TradingView Direct company coverage

Price to book forward of BioNexus Gene Lab Corp – NASDAQ:BGLC

This article provides financial data for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its "Price to book forward" metric. It states the period value and change percentages for this financial indicator. The content is presented within the context of a TradingVie

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 21:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of BioNexus Gene Lab Corp – NASDAQ:BGLC

This article provides financial data for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its Enterprise Value to EBITDA forward. The data is presented within the context of a TradingView financial analysis page, detailing market information for the company.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 17:41
Source
TradingView
TradingKey Direct company coverage

BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of BioNexus Gene Lab Corp (BGLC)'s dividend history and stock split events. It states that no dividends have been distributed in the past five years and lists one upcoming merger stock split event with a 10->1 ratio scheduled for April 3, 2025.

Tone
Neutral 50/100
Event
Deals and strategy
Published
18 Jun 2026 09:39
Source
TradingKey
TradingKey Direct company coverage

BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses the revenue breakdown for BioNexus Gene Lab Corp (BGLC), noting that relevant data regarding business segments and regional revenue and profit contribution have not yet been disclosed by the company. It highlights the current stock price and market capitaliz

Tone
Negative 38/100
Event
Earnings
Published
18 Jun 2026 08:39
Source
TradingKey
TradingKey Direct company coverage

BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of BioNexus Gene Lab Corp (BGLC), highlighting its current valuation score of 8.38 within the Biotechnology & Medical Research industry. It notes the company's P/E ratio of -1.76 and indicates that key P/B, P/S, and P/CF data have not ye

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 04:10
Source
TradingKey
TradingKey Direct company coverage

BioNexus Gene Lab Corp (BGLC) Institutional Confidence

This article from TradingKey provides an overview of institutional confidence in BioNexus Gene Lab Corp (BGLC), including its stock price, market cap, and various TradingKey Stock Scores. It details institutional shareholdings and recent changes in holdings by key investors. The

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 02:39
Source
TradingKey
TradingKey Direct company coverage

BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for BioNexus Gene Lab Corp (BGLC), indicating that no earnings forecast score is currently available for the company. It notes that the Biotechnology & Medical Research industry average is 8.13 and states that relevant data for financial

Tone
Negative 39/100
Event
Earnings
Published
18 Jun 2026 02:39
Source
TradingKey
Pluang Direct company coverage

BioNexus urges Malaysia-China biotech cooperation to evolve from trade to co-development and regional healthcare integration.

BioNexus Gene Lab Corp. calls for a deeper biotechnology collaboration between Malaysia and China, moving beyond simple trade to focus on co-development, clinical validation, and commercialization. CEO Sam Tan emphasized Malaysia's strategic position as an ASEAN hub to facilitate

Tone
Positive 74/100
Event
Market update
Published
09 Jun 2026 23:44
Source
Pluang
TradingView Direct company coverage

BioNexus Gene Lab Urges Malaysia–China Co-Development of Biotech Platforms After Kuala Lumpur Forum

BioNexus Gene Lab is advocating for increased biotechnology co-development between Malaysia and China, alongside the establishment of regional precision healthcare platforms. The company highlighted its proposals at the 2026 China–Malaysia Economic Cooperation Outlook Forum, focu

Tone
Positive 81/100
Event
Guidance
Published
05 Jun 2026 12:39
Source
TradingView
Stock Titan Direct company coverage

BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia–China biotech co-development model

BioNexus Gene Lab Corp. (Nasdaq: BGLC) is advocating for a shift in Malaysia–China biotechnology collaboration from simple trade to deeper co-development, clinical validation, and regional commercialization. The company suggests Malaysia can serve as an ASEAN "execution hub" for

Tone
Positive 67/100
Event
Market update
Published
05 Jun 2026 12:39
Source
Stock Titan
Finviz Direct company coverage

BGLC - BioNexus Gene Lab Corp Stock Price and Quote

This article provides a detailed stock quote and financial overview for BioNexus Gene Lab Corp (BGLC), including its recent stock performance, key financial metrics, and executive information. It also lists recent news announcements detailing the company's strategic partnerships,

Tone
Positive 63/100
Event
Market update
Published
02 Jun 2026 21:40
Source
Finviz
GeneOnline Direct company coverage

BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Collaboration Focused on Joint Development

BioNexus Gene Lab Corp. is advocating for a deeper biotechnology collaboration between Malaysia and China, moving beyond simple trade to focus on joint development initiatives. The company believes this shift, involving shared research, technology transfer, and co-creation of sol

Tone
Positive 71/100
Event
Market update
Published
31 May 2026 11:09
Source
GeneOnline
The Norfolk Daily News Direct company coverage

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

BioNexus Gene Lab Corp. emphasized the need for Malaysia and China to deepen their biotechnology cooperation beyond trade into co-development, clinical validation, and commercialization. Speaking at the 2026 China–Malaysia Economic Cooperation Outlook Forum, BioNexus CEO Sam Tan

Tone
Positive 82/100
Event
Guidance
Published
29 May 2026 13:10
Source
The Norfolk Daily News
Stock Titan Direct company coverage

Turning Malaysia into a bridge for China’s biotech ambitions

BioNexus Gene Lab (Nasdaq: BGLC) advocated for deeper Malaysia-China biotechnology cooperation at the 2026 China–Malaysia Economic Cooperation Outlook Forum, moving beyond trade to co-development. CEO Sam Tan proposed Malaysia as an ASEAN execution hub for precision diagnostics,

Tone
Positive 80/100
Event
Guidance
Published
29 May 2026 13:08
Source
Stock Titan